Hep G2 nuclear extract lysate (ab14660)
Overview
-
Product name
Hep G2 nuclear extract lysate
See all HepG2 lysates -
General notes
Cell line: HepG2 (Human hepatocellular carcinoma).
We recommend aliquoting the extracts into single use fractions and then storing them. -
Tested applications
Suitable for: EMSA, WBmore details
Properties
-
Mycoplasma free
Yes -
Form
Liquid -
Storage instructions
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles. -
Storage buffer
pH: 7.90
Constituents: 0.75% Potassium chloride, 0.009% PMSF, 0.01% Magnesium chloride, 0.008% DTT, 0.48% HEPES, 20% Glycerol -
Concentration information loading...
-
Research areas
-
Background
Hepatitis B virus (HBV) is the major cause of acute and chronic hepatitis, leading to progressive development of necroinflammatory changes in the liver, which can result in cirrhosis and hepatocellular carcinoma. Although the development of an effective vaccine to prevent HBV infection has shown promising results and should lead to its eventual eradication, antiviral chemotherapy remains the only effective method to prevent the progression of the disease in chronic carriers. Therefore, the development of new antiretroviral agents active against HBV is needed. HepG2 cells have an epithelial morphology and are thought to be a very useful model to study HBV virus replication via transfection. Cells are also used for cancer and apoptosis studies (in particular signalling pathway studies).
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab14660 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
EMSA |
Use at an assay dependent dilution.
|
|
WB |
Use at an assay dependent dilution.
|
Notes |
---|
EMSA
Use at an assay dependent dilution. |
WB
Use at an assay dependent dilution. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (1)
ab14660 has been referenced in 1 publication.
- Selvarajan I et al. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease. Am J Hum Genet 108:411-430 (2021). PubMed: 33626337